Not checked for notices yet.
ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis
Hao Yu, Xiao Yang, Jinyuan Tang and 8 more
Molecular Therapy: Nucleic Acids · 2021
doi:10.1016/j.omtn.2020.10.031
Cited by papers we hold 8
- Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance · 2025No notice
- m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism · 2023No notice
- The role of m6A methylation in therapy resistance in cancer · 2023No notice
- Role of m6A writers, erasers and readers in cancer · 2022No notice
- RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential · 2022No notice
- The role of m6A RNA methylation in cancer metabolism · 2022No notice
- Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance · 2022No notice
- ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.